Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IMRX · against 296 other Healthcare companies of similar size
Ranked #20 of 297 · scores higher than 94% of peers · safety percentile 96
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)41 peers with a safety percentile of 90–100, including IMRX · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | IMRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 267 reported | 0.02× | 0.19× | 83% | 33% | |
| BetaLower is better · 282 reported | 0.39 | 0.51 | 58% | 33% | |
| Current ratioHigher is better · 293 reported | 19.47× | 3.19× | 93% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 421M USD | 99 | 52 | |
| 3 | 165M USD | 99 | 50 | |
| 4 | 261M USD | 99 | 97 | |
| 5 | 397M USD | 99 | 37 | |
| 16 | 3.3B CNY (≈$458M) | 97 | 49 | |
| 17 | 258M USD | 97 | ||
| 18 | 3.4B CNY (≈$469M) | 97 | 42 | |
| 19 | 332M USD | 97 | 35 | |
| 20 | 238M USD | 96 | 41 | |
| 21 | 40.1B JPY (≈$273M) | 96 | 45 | |
| 22 | 389M USD | 96 | 33 | |
| 23 | 2.4B CNY (≈$331M) | 96 | 51 | |
| 24 | 365M USD | 95 | 41 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score